January 24-25, 2018 | Philadelphia, PA
http://www.cbinet.com/contracting
Exclusive Offer for Drug Channels Readers:
Register Now to SAVE $400*
(Use discount code HRQ997)
CBI’s 5th Annual Reimbursement & Contracting Conference is the ideal platform for bio/pharma manufacturers to unravel complexities associated with reimbursement, pricing strategies and federal and commercial contracting.
Join industry thought-leaders and colleagues in Philadelphia on January 24-25 at this CPE accredited event, and discover the necessary insights to navigate the evolving regulatory landscapes to develop innovative and competitive pricing strategies.
Featured Sessions from Our Distinguished Faculty Include:
- Hear the Latest Healthcare Updates and the Implications for Contracting and Reimbursement Strategies – Center for Medicine in the Public Interest
- Align New Technologies and New Treatment Paradigms within Existing Reimbursement Systems and Utilize AI Technologies to Enhance Efficiency – Pear Therapeutics and Magellan Method, a division of Magellan Rx Management
- Garner Best Practices to Develop Innovative Contracting and Implement Effective Pricing Strategies – Abarca Health and Alvogen Inc.
- Explore Outcomes-Based Contracting to Facilitate Enhanced Access for Biosimilars – National Institute for Health and Care Excellence (NICE)
- Overcome Key Challenges Facing the Specialty Marketplace – Intarcia Therapeutics
- And more!
- Plus, Choose Between Two In-Conference Workshops:
- A. Commercial Pricing and Contracting Master Class – Insmed Inc. and Horizon Pharma
- B. Navigate the Complexities of 340B and its Impact on Pricing and Contracting – 340B Health
Previous Attendees Acclaim:
“EXCELLENT CONFERENCE to bring the commercial and government contracting perspectives together.” - Department Director, Government Contracts & Reporting, Bayer
“EXTREMELY WELL RUN conference where ideas were shared so everyone could benefit and learn from the group!” - Business Relations Manager, Sanofi Genzyme
“The in-depth introduction of pros and cons for outcomes-based contracting OPENED THE DOOR FOR EXPLORATION.” - Senior Business Partner, Indivior
“EXTREMELY WELL RUN conference where ideas were shared so everyone could benefit and learn from the group!” - Business Relations Manager, Sanofi Genzyme
“The in-depth introduction of pros and cons for outcomes-based contracting OPENED THE DOOR FOR EXPLORATION.” - Senior Business Partner, Indivior
*Offer valid through 1/24/18; applies to standard rates only and may not be combined with other offers, category rates, promotions or applied to existing registration. Not valid on workshops only or academic/non-profit registration. CPE credits pending approval.
The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.
No comments:
Post a Comment